Suzuki Shiori, Bandoh Nobuyuki, Goto Takashi, Kubota Akinobu, Uemura Akihiro, Kono Michihisa, Sato Ryosuke, Takeda Ryuhei, Sakaue Shota, Yamaguchi-Isochi Tomomi, Nishihara Hiroshi, Takei Hidehiro, Harabuchi Yasuaki
Department of Otolaryngology-Head and Neck Surgery, Hokuto Hospital, Obihiro, Hokkaido 080-0833, Japan.
Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510, Japan.
Oncol Lett. 2022 May 13;24(1):207. doi: 10.3892/ol.2022.13328. eCollection 2022 Jul.
The aim of the present study was to analyze the clinical characteristics, surgical treatments and clinical outcome of patients with parotid gland tumors and to compare the results with those cited in the literature. A retrospective study was conducted in 140 patients (male, n=77; female, n=63) with parotid gland tumors who underwent parotidectomy at Hokuto Hospital Department of Otolaryngology-Head and Neck Surgery (Obihiro, Japan) between April 2007 and December 2021. Of the 140 patients enrolled, 118 (84.3%) patients had benign tumors, including 63 (45%) patients with pleomorphic adenomas and 43 (30.7%) patients with Warthin tumors, and 22 patients (15.7%) had parotid carcinoma. Comparison of the three groups of patients with parotid gland tumors indicated that pack years as an indicator of smoking status were significantly higher in patients with Warthin tumors than in those with parotid carcinomas (P=0.011) or pleomorphic adenoma (P<0.001). Fine-needle aspiration cytology (FNAC) was non-diagnostic for only 6 (4.3%) of 140 patients. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of FNAC by both conventional smear and liquid-based cytology (LBC) for parotid carcinomas were 70, 99, 93.3, 94.4 and 82.9%, respectively. Among the 22 patients with parotid carcinoma, extended total/total and superficial parotidectomy were performed in 10 (45%) and 11 (50%) cases, respectively. Total and selective neck dissection of the area from level II to I, II and III were performed in 6 (24%) and 7 (32%) patients, respectively. Postoperative radiotherapy (50 Gy) was performed in 15 (68%) patients. The overall survival (OS) and disease-free survival (DFS) rates at 5 years were 51.5 and 76.4%, respectively. Univariate analysis revealed that age >65 years was significantly associated with poorer 5-year OS (P<0.001) and DFS (P<0.001). Multivariate analysis revealed that an age of more than 65 years combined with high-grade histologic malignancy was associated with worse DFS (P=0.02; hazard ratio, 3.628; 95% confidence interval, 1.283-9.514). In conclusion, the clinical characteristics and treatment outcomes of parotid gland tumors were consistent with the results of previous reports. Smoking may be closely related to the pathogenesis of Warthin tumors. LBC potentially provides improved accuracy in FNAC.
本研究的目的是分析腮腺肿瘤患者的临床特征、手术治疗方法及临床结局,并将结果与文献报道进行比较。对2007年4月至2021年12月期间在日本带广市北斗医院耳鼻咽喉头颈外科接受腮腺切除术的140例腮腺肿瘤患者(男性77例,女性63例)进行了回顾性研究。在纳入的140例患者中,118例(84.3%)为良性肿瘤,其中多形性腺瘤63例(45%),沃辛瘤43例(30.7%),22例(15.7%)为腮腺癌。三组腮腺肿瘤患者的比较表明,以吸烟包年数作为吸烟状况指标,沃辛瘤患者显著高于腮腺癌患者(P=0.011)和多形性腺瘤患者(P<0.001)。140例患者中仅6例(4.3%)细针穿刺细胞学检查(FNAC)未明确诊断。传统涂片和液基细胞学检查(LBC)对腮腺癌的FNAC敏感性、特异性、阳性预测值、阴性预测值和准确性分别为70%、99%、93.3%、94.4%和82.9%。22例腮腺癌患者中,分别有10例(45%)和11例(50%)进行了扩大全腮腺/全腮腺及浅叶腮腺切除术。分别有6例(24%)和7例(32%)患者进行了ⅡⅠ、Ⅱ和Ⅲ区的全颈和选择性颈清扫术。15例(68%)患者术后接受了放疗(50 Gy)。5年总生存率(OS)和无病生存率(DFS)分别为51.5%和76.4%。单因素分析显示,年龄>65岁与较差的5年OS(P<0.001)和DFS(P<0.001)显著相关。多因素分析显示,年龄超过65岁合并高级别组织学恶性与较差的DFS相关(P=0.02;风险比,3.628;95%置信区间,1.2839.514)。总之,腮腺肿瘤的临床特征和治疗结果与既往报道一致。吸烟可能与沃辛瘤的发病机制密切相关。LBC可能提高FNAC的准确性。